Table 1.
Epidemiological and clinical characteristics of cirrhotic patients admitted into Spanish intensive care units between 2005 and 2010
| Control-group | CHC-group | p-value | |
|---|---|---|---|
| No. | 4127 | 1138 | |
| Males | 2737 (66.3 %) | 719 (63.2 %) | 0.053 |
| Age (years) | 57.2 (56.7; 57.6) | 58.2 (57.4; 58.9) | 0.030 |
| Length of hospital stay (days) | 12.5 (11.9; 13.1) | 10.7 (9.9; 11.6) | <0.001 |
| Abuse of alcohol and drugs | 1622 (39.3 %) | 342 (30.1 %) | <0.001 |
| Charlson comorbidity index | 0.91 (0.86; 0.95) | 0.75 (0.68; 0.82) | <0.001 |
| Decompensated cirrhosis | 2539 (61.5 %) | 777 (68.3 %) | <0.001 |
| General comorbidities | |||
| Cardiovascular | 3041 (73.7 %) | 830 (72.9 %) | 0.638 |
| Infectious without hepatitis | 1352 (32.8 %) | 383 (33.7 %) | 0.594 |
| Respiratory | 2212 (53.6 %) | 597 (52.5 %) | 0.517 |
| Gastrointestinal/hepatic | 4029 (97.6 %) | 1105 (97.1 %) | 0.368 |
| Neurological | 911 (22.1 %) | 263 (23.1 %) | 0.482 |
| Cancer | 296 (7.2 %) | 93 (8.2 %) | 0.281 |
| Diabetes | 692 (16.8 %) | 210 (18.5 %) | 0.196 |
Values are expressed as absolute numbers (percentages) and as the mean (95 % confidence intervals). P-values were calculated by the chi-squared test or Student’s t-test, as appropriate
Abbreviation: CHC chronic hepatitis C virus